Drugs / Ad-CEA vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03050814 | Apr 2017 → Aug 2021 | colorectal adenocarcinoma | National Cancer Institute (NCI) | Terminated | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ad-CEA vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03050814 ↗ |